Company: BLUWU
Filing Date: 2025-05-23
Form Type: S-1/A
Source: 0001641172-25-012302
Chunk: 157

Company: Blue Water Acquisition Corp. III
Filing Date: 2025-05-23
Form: S-1/A
Chunk 157
---
 Head of Department of Zoology, Chair of the University IT Committee, deputy chair of University Finance Committee, and membership of the following University committees: Council (he is a trustee of Oxford University), Finance, Planning and Resource Allocation, Nominations, and Health and Safety. In addition, Prof. Coulson has recently overseen the development of Oxford’s new four-year biology course that has resulted in a significant increase in biology undergraduate student numbers, and six new associated academic positions. Prof. Coulson has been the client representative for Oxford’s new Life and Mind Building and now serves as the academic lead on securing philanthropic donations. Prof. Coulson sits on MPLS Divisional Board and the MPLS Shared Services Sub-committee (occasional chair). He chaired the Wytham Chalet Project Sponsor Group. and holds a Professorial Fellowship at, and is a trustee of, Jesus College, Oxford. Prof. Coulson’s research interests lie in using mathematics to marry ecological and evolutionary theory that he then tests through observation and experimentation. Prof. Coulson has advised European and African governments on wildlife management, and global corporations such as Rio Tinto, on human population growth into the future. Prof. Coulson edits the leading specialist ecological journal (Ecology Letters) and has won numerous awards for his research and teaching. Prof. Coulson obtained his undergraduate degree in Biology from the University of York, and a PhD from Imperial College, London.

Dr. Trevor L. Hawkinswill serve as a member of our board of directors upon the effectiveness of the registration statement of which this prospectus forms a part. Dr. Hawkins has built a recognized career in the healthcare industry over the past 25 years spanning business, academic innovation and as an entrepreneur. Dr. Hawkins is a former director of the U.S. Department of Energy’s Human Genome Project and has diverse commercial and managerial experience at leading global companies. Dr. Hawkins currently serves on several boards in the life science industry. In April 2024, Dr. Hawkins was appointed to the Supervisory Board of Genomtec S.A., a public molecular diagnostics company based in Poland. He has been a member of the Board of Directors of Resistell AG, a medical technology company, since December 2023, and is also a member of the Science Advisory Boards of Noscendo GmbH and lifespin GmbH. Since January 2016, Dr. Hawkins has served as an Operating Advisor to GreyBird Ventures LLC, a venture capital firm focused on medical diagnostic solutions. Previously, Dr. Hawkins has held